Keyphrases
Cell-based Assay
100%
Breast Cancer
100%
Circulating Tumor Cells
100%
Prognostic Marker
50%
Predictive Marker
50%
Cancer Types
25%
Polymerase Chain Reaction
25%
Overall Survival
25%
Bone Marrow
25%
Peripheral Blood
25%
Cause of Death
25%
Metastatic Breast Cancer
25%
Lymph Node
25%
Recurrence Rate
25%
Recurrence Risk
25%
Metastatic Disease
25%
Early Breast Cancer
25%
Biological Agents
25%
Low Risk
25%
Node-positive
25%
High-risk of Recurrence
25%
Minimal Residual Disease
25%
Adjuvant Systemic Therapy
25%
Node-negative
25%
Overall Assessment
25%
Staging System
25%
Enrichment Method
25%
Assessment of Therapeutic Response
25%
Novel Chemotherapeutic Agents
25%
Body Compartments
25%
Cell Enrichment
25%
Medicine and Dentistry
Breast Cancer
100%
Circulating Tumor Cell
100%
Recurrent Disease
75%
Biological Product
25%
Adjuvant Therapy
25%
Overall Survival
25%
Minimal Residual Disease
25%
Metastatic Carcinoma
25%
Treatment Response
25%
Lymph Node
25%
Recurrence Risk
25%
Metastatic Breast Cancer
25%
Malignant Neoplasm
25%
Predictive Marker
25%
Polymerase Chain Reaction
25%